KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short-term Investments (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Short-term Investments for 17 consecutive years, with $464.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 9.55% to $464.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $464.0 million, a 9.55% decrease, with the full-year FY2025 number at $464.0 million, down 9.55% from a year prior.
  • Short-term Investments was $464.0 million for Q4 2025 at Bristol Myers Squibb, down from $1.0 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3.0 billion in Q4 2021 to a low of $130.0 million in Q4 2022.
  • A 5-year average of $1.4 billion and a median of $1.5 billion in 2021 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 95.65% in 2022, then surged 527.69% in 2023.
  • Bristol Myers Squibb's Short-term Investments stood at $3.0 billion in 2021, then tumbled by 95.65% to $130.0 million in 2022, then soared by 527.69% to $816.0 million in 2023, then plummeted by 37.13% to $513.0 million in 2024, then decreased by 9.55% to $464.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Short-term Investments are $464.0 million (Q4 2025), $1.0 billion (Q2 2025), and $513.0 million (Q4 2024).